Pharmaceutical Investing Opiant Pharmaceuticals Awarded Grant of Approximately $7.4 Million from the National Institutes of Health for Development of OPNT003
Pharmaceutical Investing EyeGate Receives FDA Feedback on Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel
Pharmaceutical Investing Pernix Therapeutics Announces Return to Market of Zohydro ER with BeadTek 20 mg
Pharmaceutical Investing Sonoma Pharmaceuticals Introduces New and Improved Acuicyn™ Antimicrobial Eyelid and Eyelash Hygiene Solution
Pharmaceutical Investing EyeGate Pharmaceuticals Reports Full-Year 2017 Financial Results and Provides Business Update
Pharmaceutical Investing Foamix Reports Fiscal Year 2017 Financial Results and Provides Corporate Update
Pharmaceutical Investing Supernus Announces Record Full Year 2017 Financial Results, Exceeding Operating Earnings Guidance